Newer antiepileptic drugs: Advantages and disadvantages

Brain and Development

Volumn 23, Issue 5, 2001, Pages 277-283

  Wallace, Sheila J ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Advantages; Disadvantages; Newer antiepileptic drugs

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CORTICOTROPIN; DIETHYLCARBAMAZINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; REMACEMIDE; STIRIPENTOL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANOREXIA; APLASTIC ANEMIA; APPETITE DISORDER; ARTICLE; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; DRUG TOLERABILITY; DRUG USE; EPILEPSY; FOCAL EPILEPSY; HEADACHE; HUMAN; HYPONATREMIA; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; LIVER TOXICITY; META ANALYSIS; MYOCLONUS EPILEPSY; NEPHROLITHIASIS; PSYCHOSIS; RASH; RISK FACTOR; SEIZURE; STEVENS JOHNSON SYNDROME; VISUAL FIELD DEFECT; VOMITING; WEIGHT REDUCTION;

EID: 0034903076     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00230-3     Document Type: Review

References (65)

1. The new antiepileptic drugs: A systematic review of their efficacy and tolerability
2. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: A single-blind, dose-increasing study
3. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms
4. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review
5. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients
6. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
7. Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized prospective study
8. VGB: A novel therapy for seizure disorders
9. Vigabatrin as initial therapy for infantile spasms: A European retrospective survey
10. Vigabatrin in intractable childhood epilepsy: A retrospective study
11. Gamma-vinyl GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: An open study
12. The potential for increased seizure frequency, relapse and appearance of new seizure types with vigabatrin
13. Severe persistent visual field constriction associated with vigabatrin
14. Electro-oculography, electroretinography, visual evoked potentials and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction
15. Visual field defects associated with vigabatrin therapy
16. Characteristics of a unique visual field defect attributed to vigabatrin
17. Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings
18. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy
19. Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: An open prospective study
20. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
21. Lamotrigine for the treatment of epilepsy in childhood
22. Lamictal (lamotrigine) monotherapy for typical absence seizures in children
23. Lamotrigine and seizure aggravation in severe myoclonic epilepsy
24. Lamotrigine in severe infantile epilepsies
25. Approaches to reducing the incidence of lamotrigine-induced rash
26. Lamotrigine-associated rash: Risk/benefit considerations in adults and children
27. Lamotrigine-associated severe cutaneous adverse reactions
28. Lamotrigine-induced carbamazepine toxicity: An interaction with carbamazepine-10, 11-epoxide
29. The tolerability of lamotrigine in children
30. Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study
31. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
32. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin
33. Gabapentin-related myoclonus
34. Gabapentin toxicity in children manifesting as behavioral changes
35. Behavioral side-effects of gabapentin in children
36. Weight gain associated with the use of gabapentin
37. Weight gain during add-on therapy using gabapentin (GBP)
38. Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
39. Effectiveness, tolerability and safety of topiramate in children with partial-onset seizures
40. Long-term response to topiramate in patients with West syndrome
41. Topiramate in Lennox-Gastaut syndrome: Open-label treatment of patients completing a randomized controlled trial
42. Tiagabine
43. Long-term treatment of partial seizures with tiagabine in children
44. Single-blind study of safety, tolerability and preliminary efficacy of tiagabine as adjunctive treatment of children with epilepsy
45. Use of tiagabine as long-term therapy for complex partial seizures in adolescents
46. Two cases of non-convulsive status epilepticus in association with tiagabine therapy
47. Frontal non-convulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria
48. Felbamate: A clinical trial for complex partial seizures
49. Felbamate monotherapy: Controlled trial in patients with partial onset seizures
50. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)
51. Felbamate for absence seizures
52. Felbamate in juvenile myoclonic epilepsy
53. The use of felbamate to treat infantile spasms
54. Felbamate
55. Oxcarbazepine
56. Oxcarbazepine in the treatment of early childhood epilepsy
57. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
58. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial
59. Clinical antiepileptic efficacy of stiripentol in resistant partial epilepsies
60. Stiripentol in atypical absence seizures in children: An open trial
61. A double-blind placebo controlled cross-over study of remacemide hydrochloride as adjunctive therapy in patients with refractory epilepsy
62. Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy
63. Zonisamide
64. Zonisamide-induced behavior disorder in two children
65. Levetiracetam for partial seizures: Results of a double-blind randomized clinical trial